|
The
booster called vaccines
Utkarsh Palnitkar, Partner, Transaction Advisory Services,
Leader-Policy and Investment Advisory Services, Industry Leader-Health
Sciences at Ernst & Young, in conversation with Nandini
Patwardhan on the Indian vaccines segment.
Jubilant
signs agreement with Syngenta
Jubilant Organosys has entered into a multi million-Dollar
long-term agreement with Syngenta for the supply of pyridines.
The new contract starts from early 2008 and covers an extension
period of up to five years.
A
glance at the other side
The latest report by Frost & Sullivan titled Indian healthcare
industry gives the low down on the economic, political and
social infrastructure of one of the most dynamic and evolving
industries in the country today.
Ipca
forays into Australia and New Zealand
Mumbai-based Ipca Laboratories has acquired 100 percent shareholding
of a small formulation product dossier registration-cum-distribution
company in Australia, now known as Ipca Pharma Australia BTY.
Baxter
brings Tisseel to India
Baxter India recently launched one of its internationally
revolutionary products, Tisseel VH in India.
Caraco
gets FDA nod for Coreg
Caraco Pharmaceutical Laboratories (CPD) has announced that
the US FDA has granted final approval for the company's ANDA
for Carvedilol Tablets, 3.125 mg, 6.25 mg, 12.5 mg and 25
mg.
Zydus's
Carvedilol receive USFDA nod
Zydus Cadila has received a USFDA approval to market Carvedilol
Tablets 3.125 mg, 6.25 mg, 12.5 mg and 25 mg, in the US market.
Fermish
inaugurated by DCGI
Fermish Clinical Technologies was inaugurated by Dr M Venkateswaralu,
Drug Controller General of India, in September 2007, at the
company office (Okhla Industrial Area, New Delhi). .
Lupin
wins Ramipril product patent challenge
Lupin has announced that the Court of Appeals for the Federal
Circuit has reversed a district court decision on Ramipril
in its favor, finding the Aventis patent on Ramipril invalid.
Ajanta
Pharma ties-up with Prollenium
Ajanta Pharma has entered into an in-licensing agreement with
Prollenium Medical Technologies of Canada and will have exclusive
marketing rights for Prollenium's dermal filler-Revanesse,
in India.
Arch
on a buying spree
Mumbai-based Arch Pharmalabs has announced the acquisition
of Hyderabad-based Watsol Organics, a manufacturer of pharmaceuticals
and agro-chemical intermediaries, for an enterprise value
of Rs 30 crore.
PerkinElmer
India ties up with ICMR; expands product base
PerkinElmer India, a wholly owned subsidiary of US based PerkinElmer,
and a global technology provider in health sciences and photonics,
has unveiled its latest generation of products, as a part
of its expansion plan for the fast growing Indian life science
and instrumentation market.
Atlas
Copco strengthens production in India
Atlas Copco has announced that it has modernized and concentrated
manufacturing at its two production sites in India, creating
local centers of competence for compressor and construction
and mining technology.
AMA
receives Best Management Association Award
The Ahmedabad Management Association was selected for the
Best Management Association Award for 2006-07 by the All India
Management Association (AIMA).
Events
Good
drugs come in great packages
And great packaging did get recognised and rewarded at the
Interphex India 2007 when the Indian Pharmaceutical Association
(IPA) and Bilcare awarded pharmaceutical companies for their
packaging initiatives. Nandini Patwardhan reports
Upcoming
Events
|
